DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 2.60% to $766.02 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.41% to 7,108.40 and Dow Jones Industrial Average falling 0.36% to 49,310.32.
The stock's rise snapped a three-day losing streak.
Regeneron Pharmaceuticals Inc. closed 6.71% short of its 52-week high of $821.11, which the company achieved on January 9th.
The stock outperformed some of its competitors Thursday, as Amgen Inc. $(AMGN)$ rose 0.78% to $348.62, Moderna Inc. (MRNA) fell 4.95% to $52.85, and Gilead Sciences Inc. (GILD) rose 0.56% to $133.64.
Trading volume (926,113) eclipsed its 50-day average volume of 652,714.
Data source: Dow Jones Market Data, FactSet. Data compiled April 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 23, 2026 16:42 ET (20:42 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments